Foresee Pharmaceuticals Co., Ltd. (6576.TWO)

TWD 66.0

(3.94%)

EBITDA Summary of Foresee Pharmaceuticals Co., Ltd.

  • Foresee Pharmaceuticals Co., Ltd.'s latest annual EBITDA in 2023 was -912.16 Million TWD , down -135.96% from previous year.
  • Foresee Pharmaceuticals Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was -131.22 Million TWD , down -52.22% from previous quarter.
  • Foresee Pharmaceuticals Co., Ltd. reported an annual EBITDA of -386.57 Million TWD in 2022, up 18.76% from previous year.
  • Foresee Pharmaceuticals Co., Ltd. reported an annual EBITDA of -475.83 Million TWD in 2021, down -10.06% from previous year.
  • Foresee Pharmaceuticals Co., Ltd. reported a quarterly EBITDA of -131.22 Million TWD for 2024 Q2, down -52.22% from previous quarter.
  • Foresee Pharmaceuticals Co., Ltd. reported a quarterly EBITDA of -309.59 Million TWD for 2023 Q4, down -57.69% from previous quarter.

Annual EBITDA Chart of Foresee Pharmaceuticals Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Foresee Pharmaceuticals Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -912.16 Million TWD -135.96%
2022 -386.57 Million TWD 18.76%
2021 -475.83 Million TWD -10.06%
2020 -432.32 Million TWD 2.53%
2019 -430.26 Million TWD 0.0%

Peer EBITDA Comparison of Foresee Pharmaceuticals Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 545.408%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 494.714%
Easywell Biomedicals, Inc. -85.5 Million TWD -966.841%
TTY Biopharm Company Limited 1.52 Billion TWD 159.838%
Synmosa Biopharma Corporation 1 Billion TWD 190.426%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 256.477%
Center Laboratories, Inc. -175.17 Million TWD -420.728%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD 3037.903%
Orient Pharma Co., Ltd. 172.39 Million TWD 629.11%
InnoPharmax Inc. -62.12 Million TWD -1368.384%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 820.062%
Excelsior Biopharma Inc. -29.36 Million TWD -3005.86%
DV Biomed Co., Ltd. 407.64 Million TWD 323.766%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 213.625%
UniPharma Co., Ltd. -16.25 Million TWD -5511.911%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 794.661%
Alar Pharmaceuticals Inc. 394.52 Million TWD 331.208%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 499.501%
Mercury Biopharmaceutical Corporation -39.03 Million TWD -2236.835%
Bioray Biotech Co., Ltd 12.13 Million TWD 7616.77%
TSH Biopharm Corporation Limited 99.35 Million TWD 1018.128%